|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/44 | (2006.01) |
| C07K 16/44 | (2013.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 31/04 | (2018.01) |
| (11) | Patento numeris | 3494143 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17751568.1 |
| Europos patento paraiškos padavimo data | 2017-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/045183 |
| Data | 2017-08-02 |
| (87) | Numeris | WO 2018/026969 |
| Data | 2018-02-08 |
| (30) | Numeris | Data | Šalis |
| 201662370580 P | 2016-08-03 | US |
| (72) |
BENDER, Kristina, Oresic , US
HENRY, Christopher, E. , US
THEOLIS, Richard , US
WU, Shuang , US
|
| (73) |
Cipla USA, Inc. ,
10 Independence Boulevard Suite 300, Warren NJ 07059,
US
|
| (54) | PLAZOMICIN ANTIBODIES AND METHODS OF USE |
| PLAZOMICIN ANTIBODIES AND METHODS OF USE |